Avidity biosciences to participate in upcoming investor conference

San diego , june 14, 2024 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that avidity management will be participating at the following upcoming conference: td cowen genetic medicines & rna summit on june 20 at 8:20 a.m. pt/11:20 a.m.
RNA Ratings Summary
RNA Quant Ranking